Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 332-340 , September 2008

Involvement of receptor-bound prorenin in development of nephropathy in diabetic db/db mice

  • Atsuhiro Ichihara, MD, PhD, FAHA

      Affiliations

    • Deparment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
    • Corresponding Author InformationCorresponding author: Atsuhiro Ichihara, MD, PhD, FAHA, Associate Professor of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. Tel: +81 3 5363 3796; fax: +81 3 3359 2745
    • ,
  • Mariyo Sakoda, MD

      Affiliations

    • Deparment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Asako Kurauchi-Mito, MD

      Affiliations

    • Deparment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • Akira Nishiyama, MD, PhD, FAHA

      Affiliations

    • Department of Pharmacology, Kagawa University School of Medicine, Kagawa, Japan
    • ,
  • Hiroshi Itoh, MD, PhD

      Affiliations

    • Deparment of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

Received 18 February 2008 ,Accepted 15 April 2008.

References 

  1. Danser AH, Deinum J. Renin, prorenin, and the putative (pro)renin receptor. Hypertension. 2005;46:1069–1076
  2. Nguyen G. Renin/prorenin receptors. Kidney Int. 2006;69:1503–1506
  3. Danser AH. Prorenin: back into the arena. Hypertension. 2006;47:824–826
  4. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417–1427
  5. Nabi AHMN, Kageshima A, Uddin M, Nakagawa T, Park E, Suzuki F. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system. Int J Mol Med. 2006;18:483–488
  6. Schefe JH, Funke-Kaiser H, Jost A, Unger T. Signal transduction of the renin/prorenin receptor. [Abstract] J Hypertens. 2005;23:S354
  7. Derkx F, Schalekamp M. Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens. 1988;A10:1213–1225
  8. Wilson D, Leutscher JA. Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med. 1990;323:1101–1106
  9. Deinum J, Rønn B, Mathiesen E, Derkx FHM, Hop WCJ, Schalekamp MADH. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999;42:1006–1010
  10. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for non-proteolytic activation of prorenin. J Clin Invest. 2004;114:1128–1135
  11. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol. 2006;17:1950–1961
  12. Takahashi H, Ichihara A, Kaneshiro Y, Inomata K, Sakoda M, Takemitsu T, et al. Regression of nephropathy developed in diabetes by (pro)renin receptor blockade. J Am Soc Nephrol. 2007;18:2054–2061
  13. Suzuki F, Hayakawa M, Nakagawa T, Nasir UM, Ebihara A, Iwasawa A, et al. Human prorenin has “gate and handle” regions for its non-proteolytic activation. J Biol Chem. 2003;278:22217–22222
  14. El-Nahas AM, Bassett AH, Cope GH, Carpentier JE. Role of growth hormone in the development of experimental renal scarring. Kidney Int. 1991;40:29–34
  15. Takii Y, Figueiredo AFS, Inagami T. Application of immunochemical methods to the identification and characterization of rat kidney inactive renin. Hypertension. 1985;7:236–243
  16. Inagami T, Murakami T, Higuchi K, Nakajo S. Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Am J Hypertens. 1991;4:15S–22S
  17. Iwai N, Inagami T, Ohmichi N, Kinoshita M. Renin is expressed in rat macrophage/monocyte cells. Hypertension. 1996;27:399–403
  18. Hirota N, Ichihara A, Koura Y, Hayashi M, Saruta T. Phospholipase D contributes to transmural pressure control of prorenin processing in juxtaglomerular cell. Hypertension. 2002;39:363–367
  19. Naito Y, Tsujino T, Fujioka Y, Ohyanagi M, Iwasaki T. Augmented diurnal variations of the cardiac renin-angiotensin system in hypertensive rats. Hypertension. 2002;40:827–833
  20. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, et al. Renin increases mesangial cell transforming growth factor-b1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int. 2006;69:105–113
  21. Huang Y, Noble N, Zhang J, Xu C, Border W. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int. 2007;72:42–52
  22. Hong SW, Isono M, Chen S, Iglesias-de-la-Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor-s1, its type II receptor, and activation of the smad signaling pathway in the db/db mouse. Am J Pathol. 2001;158:1653–1663
  23. Nabi AHMN, Uddin M, Nakagawa T, Iwata H, Ichihara A, Inagami T, et al. Role of “handle” region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor. Front Biosci. 2007;12:4810–4817
  24. Batenburg WW, Krop MK, Garrelds IM, deVries R, deBruin RJA, Burckle CA, et al. Prorenin is the endogenous agonist of the (pro)renin receptor (Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor). J Hypertens. 2007;25:2441–2453
  25. Feldt S, Batenburg WW, Mazak I, Maschke U, Wellner M, Kvakan H, et al. Prorenin and renin-induced extracellular signal regulated kinase 1/2 activation in monocytes is not blocked by aliskiren or the handle-region peptide. Hypertension. 2008;51:682–688
  26. Sakoda M, Ichihara A, Kaneshiro Y, Takemitsu T, Nakazato Y, Migita T, et al. (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hyper Res. 2007;30:1139–1146
  27. Schefe J, Menk M, Reinemund J, Effertz K, Hobbs R, Pandolfi P, et al. A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res. 2006;99:1355–1366
  28. Susic D, Lippton H, Knight M, Frohlich ED. Cardiovascular effects of non-proteolytic activation of prorenin. Hypertension. 2006;48:e113
  29. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, et al. Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension. 2006;47:894–900
  30. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, et al. Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol. 2006;17:2495–2503
  31. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN. The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol. 2008;19:743–748
  32. Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, et al. (Pro)renin receptor peptide inhibitor “handle-region” peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension. 2008;51:676–681
  33. Krebs C, Hamming I, Sadaghiani S, Steinmetz OM, Meyer-Schwesinger C, Fehr S, et al. Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int. 2007;72:725–730
  34. Achard V, Boullu-Ciocca S, Desbriere R, Nguyen G, Grino M. Renin receptor expression in human adipose tissue. Am J Physiol. 2007;292:R274–R282
  35. Moriyama T, Oka K, Ueda H, Imai E. Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes. Clin Exp Nephrol. 2004;8:230–236
  36. Kelly DJ, Zhang Y, Moe G, Nail G, Gilbert RE. Aliskiren, a novel renin inhibitor, is renoprotective in a model of advanced diabetic nephropathy in rats. Diabetologia. 2007;50:2398–2404

 This work was supported in part by Grants from the Ministry of Education, Culture, Sports, Science and Technology (17390249), from the Takeda Science Foundation, and from the Japan Diabetes Foundation.

 Conflict of interest: none.

PII: S1933-1711(08)00054-5

doi: 10.1016/j.jash.2008.04.009

Journal of the American Society of Hypertension
Volume 2, Issue 5 , Pages 332-340 , September 2008

Article Tools

* Image Usage & Resolution